Ho Carole Insider Trades

Insider Trading History

Track insider trading activity for Ho Carole. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $253k 4,545 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$254k 4,545 shares
$55.87
$55.67
Lilly(Eli)
Lilly(Eli) LLY
EVP & Pres, Lilly Neuroscience
Holding Value $0 0 shares
Last Trade
Dec 31, 2025 Sale
$2.94M 2,741 shares
$1,071.64
$1,154.27
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $4.91M 216,585 shares
Last Trade
Aug 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.8k 806 shares
$14.64
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $4.92M 217,391 shares
Last Trade
Aug 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.9k 2,937 shares
$13.58
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $4.99M 220,328 shares
Last Trade
Aug 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$638k 44,655 shares
$14.29
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $1.42M 62,500 shares
Last Trade
Aug 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$638k 44,655 shares
$14.29
$22.65
Beam Therapeutics
Beam Therapeutics BEAM
Director
Holding Value $1.04M 33,662 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$577k 33,662 shares
$17.15
$30.89
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $3.98M 175,673 shares
Last Trade
Jan 07, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$60.5k 2,907 shares
$20.81
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $4.04M 178,580 shares
Last Trade
Jan 06, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$248k 12,255 shares
$20.22
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $4.32M 190,835 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.46M 162,540 shares
$21.26
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $3.1M 136,655 shares
Last Trade
Nov 25, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$437k 17,845 shares
$24.50
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $2.43M 107,155 shares
Last Trade
Nov 25, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$437k 17,845 shares
$24.50
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $2.82M 124,717 shares
Last Trade
Aug 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$492k 20,005 shares
$24.57
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $3.14M 138,815 shares
Last Trade
Aug 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.4k 2,453 shares
$23.79
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $3.2M 141,268 shares
Last Trade
Aug 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$53.5k 2,337 shares
$22.89
$22.65
Beam Therapeutics
Beam Therapeutics BEAM
Director
Holding Value $714k 23,114 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$566k 23,114 shares
$24.49
$30.89
Ngm Biopharmaceuticals
Ngm Biopharmaceuticals NGM
Director
Holding Value $0 0 shares
Last Trade
Apr 05, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$249k 161,763 shares
$1.54
$1.54
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $3.25M 143,605 shares
Last Trade
Feb 14, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$25k 1,405 shares
$17.79
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $3.28M 145,010 shares
Last Trade
Feb 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.1k 2,784 shares
$17.29
$22.65
Denali Therapeutics
Denali Therapeutics DNLI
Chief Medical Officer
Holding Value $3.35M 147,794 shares
Last Trade
Jan 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$88.8k 4,668 shares
$19.02
$22.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up